Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Nov 6;6(11):ofz436. doi: 10.1093/ofid/ofz436

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

PMC Copyright notice

Figure 2. — Sustained clinical cure of Clostridioides (Clostridium) difficile infection at 30 days after end of treatment by BioFire results at screening (mFAS). BioFire groups are based on results at screening: Group 1, positive for C difficile only; Group 2, positive for C difficile and another pathogen; Group 3, negative for C difficile but positive for another pathogen; Group 4, negative for all pathogens. ^a, P value derived from Cochran-Mantel-Haenszel test, adjusting for baseline stratification factors. ^b, P value derived from χ ² test. mFAS, modified full analysis set (all randomized patients with positive local laboratory test for C difficile toxin A/B at screening, who received at least 1 dose of study medication); N/A, not available.